Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Dec 03, 07:57 PM

Headliner
Share
Subscribe

In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins agency-wide deployment of new agentic AI tools, and a new report suggests Richard Pazdur is stepping down as director of CDER.

Share
Subscribe
Next
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive